Study raises new questions about Merck pill Zetia (AP)

AP - A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.

Read more | Previous | Next